▼ Summary
– Xuewu Liu, an uncredentialed Chinese inventor, charges cancer patients $20,000 for an unproven AI-driven treatment involving toxic chlorine dioxide injections.
– A patient reported her tumor grew faster after the procedure, though Liu denies the treatment caused cancer spread, and experts say it likely violates US regulations.
– Liu is collaborating with a Texas-based former pharmaceutical executive to bring his treatment to the US, hoping Robert F. Kennedy Jr.’s potential health secretary role will ease approval.
– Kennedy’s movement supports alternative medicine and patient freedom to try unproven treatments, while the FDA’s removal of a chlorine dioxide warning has emboldened proponents.
– Liu claims the FDA’s warning removal could lead to more research on chlorine dioxide, though the agency states it was part of routine website archiving.
A controversial inventor is promoting an unproven cancer treatment involving bleach injections, raising serious concerns among medical professionals. Xuewu Liu, a Chinese entrepreneur without medical qualifications, claims his AI-assisted therapy can destroy tumors by injecting chlorine dioxide, a potent bleach solution, directly into cancerous growths. Patients are reportedly paying $20,000 for the experimental procedure, despite warnings from experts about its potential dangers.
One patient shared her alarming experience, revealing her tumor expanded rapidly after receiving the treatment. She suspects the injections may have accelerated her cancer’s spread, though Liu denies any connection. Medical authorities argue his methods violate regulatory standards, yet he continues offering the therapy in China and a German clinic. Now, with backing from a former pharmaceutical executive in Texas, Liu aims to introduce his treatment to the U.S., banking on shifting attitudes toward alternative medicine.
The inventor has tied his hopes to Robert F. Kennedy Jr.’s advocacy for patient choice in medical treatments. While Kennedy hasn’t publicly endorsed Liu’s bleach injections, his broader support for unproven therapies has emboldened proponents of controversial remedies. The FDA recently removed a warning about chlorine dioxide from its website, a move Liu interprets as a positive signal, though the agency insists it was merely routine maintenance.
Liu remains optimistic, stating that reduced regulatory scrutiny could pave the way for clinical trials. “This change won’t transform everything overnight,” he said, “but it’s a step toward legitimizing research.” Meanwhile, oncologists caution that injecting bleach poses severe risks, with no credible evidence supporting its efficacy against cancer. The debate highlights growing tensions between medical science and fringe therapies gaining traction in certain circles.
(Source: Ars Technica)
